The Role of Neutrophils and Neutrophil Extracellular Traps in Vascular Damage in Systemic Lupus Erythematosus

被引:47
作者
O'Neil, Liam J. [1 ]
Kaplan, Mariana J. [1 ]
Carmona-Rivera, Carmelo [1 ]
机构
[1] NIAMSD, Syst Autoimmun Branch, NIH, Bethesda, MD 20892 USA
关键词
neutrophils; atherosclerosis; interferon; vascular damage; HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; POLYMORPHONUCLEAR LEUKOCYTES; CARDIOVASCULAR-DISEASE; INNATE IMMUNITY; I INTERFERON; RISK-FACTORS; ATHEROSCLEROSIS; CELLS;
D O I
10.3390/jcm8091325
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Systemic lupus erythematosus (SLE) is an autoimmune syndrome of unknown etiology, characterized by multi-organ inflammation and clinical heterogeneity. SLE affects mostly women and is associated with a high risk of cardiovascular disease. As the therapeutic management of SLE improved, a pattern of early atherosclerotic disease became one of the hallmarks of late disease morbidity and mortality. Neutrophils emerged as important players in SLE pathogenesis and they are associated with increased risk of developing atherosclerotic disease and vascular damage. Enhanced neutrophil extracellular trap (NET) formation was linked to vasculopathy in both SLE and non-SLE subjects and may promote enhanced coronary plaque formation and lipoprotein dysregulation. Foundational work provided insight into the complex relationship between NETs and immune and tissue resident cells within the diseased artery. In this review, we highlight the mechanistic link between neutrophils, NETs, and atherosclerosis within the context of both SLE and non-SLE subjects. We aim to identify actionable pathways that will drive future research toward translational therapeutics, with the ultimate goal of preventing early morbidity and mortality in SLE.
引用
收藏
页数:13
相关论文
共 89 条
  • [1] Increased prevalence of vulnerable atherosclerotic plaques and low levels of natural IgM antibodies against phosphorylcholine in patients with systemic lupus erythematosus
    Anania, Cristina
    Gustafsson, Thomas
    Hua, Xiang
    Su, Jun
    Vikstrom, Max
    de Faire, Ulf
    Heimburger, Mikael
    Jogestrand, Tomas
    Frostegard, Johan
    [J]. ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)
  • [2] Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up study
    Bengtsson, C.
    Ohman, M-L
    Nived, O.
    Dahlqvist, S. Rantapaa
    [J]. LUPUS, 2012, 21 (04) : 452 - 459
  • [3] To NET or not to NET: current opinions and state of the science regarding the formation of neutrophil extracellular traps
    Boeltz, Sebastian
    Amini, Poorya
    Anders, Hans-Joachim
    Andrade, Felipe
    Bilyy, Rostyslav
    Chatfield, Simon
    Cichon, Iwona
    Clancy, Danielle M.
    Desai, Jyaysi
    Dumych, Tetiana
    Dwivedi, Nishant
    Gordon, Rachael Ann
    Hahn, Jonas
    Hidalgo, Andres
    Hoffmann, Markus H.
    Kaplan, Mariana J.
    Knight, Jason S.
    Kolaczkowska, Elzbieta
    Kubes, Paul
    Leppkes, Moritz
    Manfredi, Angelo A.
    Martin, Seamus J.
    Maueroder, Christian
    Maugeri, Norma
    Mitroulis, Ioannis
    Munoz, Luis E.
    Nakazawa, Daigo
    Neeli, Indira
    Nizet, Victor
    Pieterse, Elmar
    Radic, Marko Z.
    Reinwald, Christiane
    Ritis, Konstantinos
    Rovere-Querini, Patrizia
    Santocki, Michal
    Schauer, Christine
    Schett, Georg
    Shlomchik, Mark Jay
    Simon, Hans-Uwe
    Skendros, Panagiotis
    Stojkov, Darko
    Vandenabeele, Peter
    Vanden Berghe, Tom
    van der Vlag, Johan
    Vitkov, Ljubomir
    von Koeckritz-Blickwede, Maren
    Yousefi, Shida
    Zarbock, Alexander
    Herrmann, Martin
    [J]. CELL DEATH AND DIFFERENTIATION, 2019, 26 (03) : 395 - 408
  • [4] Bonciani D, 2016, CLIN EXP RHEUMATOL, V34, P76
  • [5] Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State
    Borissoff, Julian I.
    Joosen, Ivo A.
    Versteylen, Mathijs O.
    Brill, Alexander
    Fuchs, Tobias A.
    Savchenko, Alexander S.
    Gallant, Maureen
    Martinod, Kimberly
    ten Cate, Hugo
    Hofstra, Leonard
    Crijns, Harry J.
    Wagner, Denisa D.
    Kietselaer, Bas L. J. H.
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (08) : 2032 - 2040
  • [6] Granules of the human neutrophilic polymorphonuclear leukocyte
    Borregaard, N
    Cowland, JB
    [J]. BLOOD, 1997, 89 (10) : 3503 - 3521
  • [7] Neutrophil subsets and their gene signature associate with vascular inflammation and coronary atherosclerosis in lupus
    Carlucci, Philip M.
    Purmalek, Monica M.
    Dey, Amit K.
    Temesgen-Oyelakin, Yenealem
    Sakhardande, Simantini
    Joshi, Aditya A.
    Lerman, Joseph B.
    Fike, Alice
    Davis, Michael
    Chung, Jonathan H.
    Playford, Martin P.
    Naqi, Mohammad
    Mistry, Pragnesh
    Gutierrez-Cruz, Gustavo
    Dell'Orso, Stefania
    Naz, Faiza
    Salahuddin, Taufiq
    Natarajan, Balaji
    Manna, Zerai
    Tsai, Wanxia L.
    Gupta, Sarthak
    Grayson, Peter
    Teague, Heather
    Chen, Marcus Y.
    Sun, Hong-Wei
    Hasni, Sarfaraz
    Mehta, Nehal N.
    Kaplan, Mariana J.
    [J]. JCI INSIGHT, 2018, 3 (08):
  • [8] Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2
    Carmona-Rivera, Carmelo
    Zhao, Wenpu
    Yalavarthi, Srilakshmi
    Kaplan, Mariana J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (07) : 1417 - 1424
  • [9] HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE
    CLARKE, R
    DALY, L
    ROBINSON, K
    NAUGHTEN, E
    CAHALANE, S
    FOWLER, B
    GRAHAM, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1149 - 1155
  • [10] Type I Interferon in the Pathogenesis of Lupus
    Crow, Mary K.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (12) : 5459 - 5468